ReviewOncology reports2026

CXCL1 in triple‑negative breast cancer: Mechanisms, challenges, and therapeutic opportunities (Review).

Hiba Al Sayegh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.